Found 31 matching trials
Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma PHASE2 This Single-arm, multicentre, phase 2 trial aims determine the activity and...
Show More Location
Border Medical Oncology Research Unit
Learn More & Join Trial
Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI PHASE2 Treatment for sublesional bone loss (osteoporosis) in persons with chronic,...
Show More Status
Active Not Recruiting
Location
Kessler Institute for Rehabilitation
Learn More & Join Trial
Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone PHASE2 To determine how safe and effective denosumab is in treating patients with ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Compare SB16 (Proposed Denosumab Biosimilar) to Prolia® in Postmenopausal Women With Osteoporosis PHASE3 This is a randomised, double-blind, multicentre study to evaluate the effic...
Show More Location
SB Investigative Site
Learn More & Join Trial
Denosumab and Nivolumab Combination As 2d-line Therapy in Stage IV NSC Lung Cancer with Bone Metastases (DENIVOS) PHASE2 Bone metastases are common in Non-Small Cell Lung Cancer (NSCLC). They most...
Show More Learn More & Join Trial
The Optimal Long Term Treatment Strategy of Anti-resorptive Medications PHASE4 This study is to investigate whether the alternating use of Prolia (Denosum...
Show More Status
Active Not Recruiting
Location
National Taiwan University Hospital, Yunlin branch
Learn More & Join Trial
Denosumab in Current Users of Bisphosphonates for Glucocorticoid-induced Osteoporosis PHASE4 The purpose of this study is to study the efficacy of denosumab, a new drug...
Show More Location
Tuen Mun Hospital
Learn More & Join Trial
Surgery vs. No Surgery for Primary Tumor in De Novo Stage IV Breast Cancer With Solitary Bone Metastases NA This is a national multicenter, prospective, randomized controlled trial. T...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of HLX14 vs. Denosumab Prolia® in Postmenopausal Women With Osteoporosis at High Risk of Fracture PHASE3 This is a randomized, double-blind, international multicentre, parallel-con...
Show More Location
The First Hospital of Hebei Medical University
Learn More & Join Trial
An Exploratory Study of Tislelizumab in Combination with Chemotherapy in Immuno-experienced Patients with EGFR/ALK/ROS1-negative Advanced NSCLC in the Second-line Setting PHASE2 The goal of this clinical trial is to explore the efficacy and safety of de...
Show More Location
Shanghai Pulmonary Hospital
Learn More & Join Trial